% | $
Quotes you view appear here for quick access.

Athersys, Inc. Message Board

nkl0145 19 posts  |  Last Activity: 15 hours ago Member since: Mar 21, 2014
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Great article and video to go along with it.


    Sentiment: Strong Buy

  • Pluripotent Stem Cells are believed to be one of the most powerful types of stem cells. For those who may not be aware Athersys MAPC cells are Pluripotent cells.


    Sentiment: Strong Buy

  • Mesoblast's full approval for GVHD in Japan has laid the ground work for MAPC approval. Athersys MAPC technology is believed to be better than Mesoblast's MSC's.

    Do you really think Chugai going to walk away from this ? I don't think so Japan has made too big a commitment to Regenerative Medicine.

    Sentiment: Strong Buy

  • Reply to

    Athersys posts new video

    by athersyss Sep 17, 2015 3:55 PM
    nkl0145 nkl0145 Sep 20, 2015 10:25 AM Flag

    This video is obviously a subtle way of management telling us that all is well... Be Patient

    I believe there are other areas being looked at above and beyond stroke and it is taking time to go through them.

    Mesoblast's full approval in Japan has laid the ground work for MAPC approval. Remember Athersys MAPC technology is believed to be better than Mesoblast's MSC's.

    Sentiment: Strong Buy

  • Reply to

    some dude named van bokkelen

    by athersyss Sep 15, 2015 4:45 PM
    nkl0145 nkl0145 Sep 15, 2015 5:06 PM Flag

    We're getting closer, Betsy Nabel, MD Chief Medical Advisor; National Football League will be there. I hope Gil and Betsy get to sit at the same table for lunch. : ))

  • Reply to

    Strong evidence of efficacy

    by cychbulll Sep 8, 2015 10:21 AM
    nkl0145 nkl0145 Sep 14, 2015 4:58 PM Flag

    And please don't forget we are dealing with one of the most unmet medical needs in medicine today.

    Sentiment: Strong Buy

  • Reply to

    Strong evidence of efficacy

    by cychbulll Sep 8, 2015 10:21 AM
    nkl0145 nkl0145 Sep 14, 2015 3:07 PM Flag

    MultiStem administered within 36 hours, the data speaks for itself. The End...

    Sentiment: Strong Buy

  • Reply to

    Bj Lehman update

    by markifeldman Sep 14, 2015 10:07 AM
    nkl0145 nkl0145 Sep 14, 2015 10:15 AM Flag

    Thank you Mark, your initiative and perspective are greatly appreciated.

  • Reply to

    Athersys receives patents in Japan

    by athersyss Sep 8, 2015 10:07 AM
    nkl0145 nkl0145 Sep 8, 2015 2:27 PM Flag

    In case anyone forgot, as part of a collaboration initiated in 2001, Athersys continues to apply its proprietary RAGE(R) technology to provide Bristol-Myers Squibb with validated drug targets for high throughput screening and lead optimization. Over the course of the multi-year partnership, Athersys has successfully delivered drug targets to Bristol-Myers Squibb from distinct target classes and in a variety of therapeutic areas. These targets provide the foundation for several active drug development programs at Bristol-Myers Squibb. Recently, Bristol-Myers Squibb has submitted an IND for a compound discovered using a RAGE target, triggering the first clinical milestone payment related to the collaboration. "We remain committed to supporting our partnership with Bristol-Myers Squibb and are delighted that the RAGE technology is playing a useful role in our partner's drug discovery efforts," said John Harrington, Ph.D., Executive Vice President and Chief Scientific Officer. "In addition to the milestone payment to Athersys, the advancement of a compound to the IND stage represents an important technical milestone and further demonstrates the value of the RAGEtechnology in the drug discovery process. At Athersys, the RAGE technology continues to provide a foundation for our own drug discovery and development programs."

  • Reply to

    NFL and MultiStem

    by nkl0145 Aug 21, 2015 8:00 AM
    nkl0145 nkl0145 Sep 6, 2015 12:25 PM Flag

    Seriously, if were a little more articulate i would attempt drafting an email to Goodell and the NFL

    Roger Goodell was recently summoned to appear before congress addressing the NFL's policies on concussions and long term health issues associated with head injuries. It appears Congress has the time to scrutinize the NFL for not doing enough to protect players while the FDA is clearly dragging its feet with a safe product that would clearly have a positive impact.

  • Reply to

    Thoughts on Chugai

    by necer149 Aug 28, 2015 6:37 AM
    nkl0145 nkl0145 Aug 28, 2015 12:24 PM Flag

    Correct Surv, and that corresponds with the mid-sept. time frame that BJ gave Mark.

  • Reply to

    Got return call from Lehmann....update

    by markifeldman Aug 21, 2015 7:47 PM
    nkl0145 nkl0145 Aug 23, 2015 11:19 AM Flag

    Thank you Mark you make some good points, i particularly like the point you make about partnering with a company with political connections and marketing savvy. It is very clear at this point in time we lack both and with an FDA that is probably as dis-functional as our government it will be extremely difficult to get anything done on our own. Our potential suitors realize this and with what has been characterized as marginal study results they kind of have us over a barrel. One of the saving graces that we claim to have are other companies that are ready to step in if Chugai decides to play hard ball. If they do decide to walk Athersys better be ready to announce their back plan immediately because the market will show no mercy if they don't.

    If Chugai truly believes in the science I believe that one of the options being discussed is a buyout price. In 3 or 4 years ATHX could easily be a $40 to $50 stock. It would not surprise me one bit if Chugai or Roche make an offer in the area of $15 to $20. At this point in time most investors will look at it in terms of " a bird in the hand is worth two in the bush".

    Obviously this is total speculation on my part but definitely something to think about.

  • With all the recent concern around head injuries ( concussions ) and the long term effect on NFL players how long will it take the NFL to provide MultiStem to players who have suffered a concussion. Someone needs to give Roger Goodell a phone call.

    Talk about PR, now that would be some real PR.

    Sentiment: Strong Buy

  • nkl0145 nkl0145 Jul 21, 2015 12:03 PM Flag

    I totally agree Matty, their lucrative compensation with lack of share price appreciation sometimes makes me think these guys are in a bubble oblivious to shareholders that have given them the substance to stay alive. They know they have a winner but they are having one hell of a time putting the pieces of the puzzle together. Granted the technology is new but i honestly feel we would all be better off served by a company that has all the resources necessary to more MultiStem forward in a timely manner. TIME does matter...

  • nkl0145 nkl0145 Jul 21, 2015 11:17 AM Flag

    A buyout is without a doubt a strong possibility. The question is what buyout price will Gil deem as fair and shareholders accept ?

    Unfortunately failed trials and credibility have placed much doubt in the minds of the common investor, most are fatigued and just want this to be over.

    Athersys management has stated that a hostile takeover is definitely a concern.

    Understand that Big Pharma are masters at recognizing value and capitalizing on vulnerability, we'll see what happens...

    Sentiment: Strong Buy

  • Reply to

    Here is whole news article on MI finding

    by williamtomko Jul 13, 2015 10:57 PM
    nkl0145 nkl0145 Jul 14, 2015 12:51 PM Flag

    Based on this article and many others like it I find it hard to believe that Chugai will not move forward with IS. As a matter of fact I believe we will see more partnerships with Chugai as time goes on. IMO this is just the beginning of a long and lasting relationship. Chugai will fill the void on the business end and polish this gem of a company so it starts to shine like it should have a long time ago.

    Sentiment: Strong Buy

  • Reply to

    Day 33.....Countdown continues..... : D

    by yags_2001 Jul 13, 2015 8:02 AM
    nkl0145 nkl0145 Jul 13, 2015 7:07 PM Flag

    Matty, i agree with your statement they are lacking in overall business skills, however the science trumps the lack of business skills and Chugai will fill the void.

    Sentiment: Strong Buy

  • Reply to

    Day 36.....Countdown continues.... : D

    by yags_2001 Jul 10, 2015 9:15 AM
    nkl0145 nkl0145 Jul 11, 2015 1:52 PM Flag

    Just to refresh everyone's memory Dr. Lee E. Babiss Ph.D. is Lead Independent Director of Athersys Inc. Dr. Babiss is currently Chief Scientific Officer and Executive Vice President of Discovery Innovation of PPD Inc. a contract research organization where he has served since February 2010 and Chief Executive Officer of XRx a majority owned subsidiary of PPD Inc. providing strategic direction and scientific leadership in support of drug discovery. Dr. Babiss was formerly President and Director of Global Pharmaceutical Research at Roche a pharmaceutical company from 1998 until his appointment at PPD Inc. Prior to Roche Dr. Babiss spent seven years with Glaxo Inc. now GlaxoSmithKline a pharmaceutical company where he held senior positions including Vice President of Biological Sciences and Genetics. Dr. Babiss received his doctorate in Microbiology from Columbia University and completed his postdoctoral fellowship at the Rockefeller University where he served as an assistant and associate professor. Dr. Babiss has holds numerous fellowship awards and grants and serves on several scientific advisory committees and boards. Also remember Roche owns 60% of Chugai.

    Sentiment: Strong Buy

  • Nate,
    I am flattered that you have taken such a great interest in my well being. I am doing great thank you, I have been traveling and playing quite a bit of golf, how about you ?

    In case you are wondering I have not sold one share of my holdings in ATHX, in fact I have picked up more shares today and am as bullish now as I have ever been. In case you have not noticed the Regenerative Medicine space is predicted to grow to approximately 24.7 Billion by 2017. If you think Athersys will not play a key role in this space you are misinformed. Chugai will move forward with Athersys and PPS will appreciate.

    Good luck collecting other peoples shares via your targeted propaganda, however you and your friends will not intimidate me.

    I have an old Jamaican friend that once told me " Time is longer than rope" and I have the time and you my friend are holding the rope.

    Sentiment: Strong Buy

1.08+0.01(+0.93%)Oct 2 4:00 PMEDT